Foster City, CA, United States of America

Michael J Romanowski

This inventor holds 1 USPTO granted patent. Top assignee: Sunesis Pharmaceuticals, Inc.. Active years: 2006.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Michael J Romanowski. Retrieved from https://idiyas.com/inventor/michael-j-romanowski-4mm9448s

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


Average Co-Inventor Count = 5.0

ph-index = 1


Company Filing History:


Years Active: 2006

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Michael J Romanowski: Innovator in Pharmaceutical Science

Introduction

Michael J Romanowski is a notable inventor based in Foster City, CA (US). He has made significant contributions to the field of pharmaceutical science, particularly in the development of innovative treatments.

Latest Patents

Romanowski holds a patent for "Caspase-1 inhibitors and methods for their use." This invention provides compounds of Formula I and derivatives thereof, pharmaceutical compositions comprising a compound of Formula I, and methods of treatment utilizing such compounds and compositions. He has 1 patent to his name.

Career Highlights

Romanowski is currently associated with Sunesis Pharmaceuticals, Inc., where he applies his expertise in drug development and innovation. His work focuses on creating effective therapeutic solutions that address critical health issues.

Collaborations

He has collaborated with notable colleagues, including Darin Allen and Bruce Fahr, to advance research and development in the pharmaceutical sector.

Conclusion

Michael J Romanowski's contributions to pharmaceutical science exemplify the impact of innovation in healthcare. His work continues to pave the way for new treatment methodologies.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…